PriceTargets.com logo

Mobia Medical - MOBI Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $20.25
  • Forecasted Upside: 66.67%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$12.15 As of 07/17/2026 05:00 PM ET
▲ +0.13 (1.08%)

This chart shows the closing price for MOBI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Mobia Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MOBI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MOBI

Analyst Price Target is $20.25
▲ +66.67% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Mobia Medical in the last 3 months. The average price target is $20.25, with a high forecast of $31.00 and a low forecast of $15.00. The average price target represents a 66.67% upside from the last price of $12.15.

This chart shows the closing price for MOBI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 polled investment analysts is to moderate buy stock in Mobia Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/23/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/22/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/20/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/18/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2026
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/17/2026
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/17/2026

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/3/2026Zacks ResearchUpgradeHold
6/2/2026Wolfe ResearchInitiated CoverageOutperform
6/2/2026The Goldman Sachs GroupInitiated CoverageBuy$31.00
6/2/2026The Goldman Sachs GroupInitiated CoverageBuy$31.00
6/2/2026JPMorgan Chase & Co.Initiated CoverageOverweight$15.00
6/2/2026BTIG ResearchInitiated CoverageBuy$19.00
6/2/2026Bank of AmericaInitiated CoverageBuy$16.00
(Data available from 7/17/2021 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/19/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/18/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/17/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/19/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/18/2026
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
5/18/2026
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/17/2026
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/17/2026

Current Sentiment

  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Mobia Medical logo
Read More

Today's Range

Now: $12.15
Low: $11.68
High: $12.40

50 Day Range

MA: $12.92
Low: $11.01
High: $14.63

52 Week Range

Now: $12.15
Low: $10.19
High: $15.29

Volume

63,586 shs

Average Volume

171,111 shs

Market Capitalization

$403.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.84

Frequently Asked Questions

What sell-side analysts currently cover shares of Mobia Medical?

The following Wall Street analysts have issued reports on Mobia Medical in the last year: Bank of America Corporation, BTIG Research, JPMorgan Chase & Co., The Goldman Sachs Group, Inc., Wall Street Zen, Wolfe Research, and Zacks Research.
View the latest analyst ratings for MOBI.

What is the current price target for Mobia Medical?

0 Wall Street analysts have set twelve-month price targets for Mobia Medical in the last year. Their average twelve-month price target is $20.25, suggesting a possible upside of 68.5%. The Goldman Sachs Group, Inc. has the highest price target set, predicting MOBI will reach $31.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $15.00 for Mobia Medical in the next year.
View the latest price targets for MOBI.

What is the current consensus analyst rating for Mobia Medical?

Mobia Medical currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MOBI.